5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates
2025

New Compounds Targeting Cancer Enzymes

publication 10 minutes Evidence: moderate

Author Information

Author(s): Ester Colarusso, Gianluigi Lauro, Marianna Potenza, Paola Galatello, Maria Luisa d'Aulisio Garigliota, Maria Grazia Ferraro, Marialuisa Piccolo, Maria Giovanna Chini, Carlo Irace, Pietro Campiglia, Robert Klaus Hoffstetter, Oliver Werz, Anna Ramunno, Giuseppe Bifulco

Primary Institution: Department of Pharmacy University of Salerno

Hypothesis

Can 5-methyl-2-carboxamidepyrrole-based compounds effectively inhibit mPGES-1 and sEH to reduce cancer progression?

Conclusion

The study identified new compounds that effectively inhibit mPGES-1 and sEH, showing potential as anticancer agents.

Supporting Evidence

  • Compounds 1f, 2b, 2c, and 2d significantly reduced mPGES-1 activity.
  • Compound 2b showed the highest potency with an IC50 of 3.3 µM.
  • Dual inhibitors demonstrated promising anticancer activities against colorectal cancer cell lines.

Takeaway

Scientists created new drugs that can help fight cancer by blocking certain enzymes that tumors need to grow.

Methodology

The study involved designing and synthesizing new compounds, followed by in vitro assays to test their effectiveness against cancer-related enzymes.

Limitations

Further studies are needed to optimize the compounds for better safety and selectivity.

Statistical Information

P-Value

1.5 ± 0.2 µM for compound 2b

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/ardp.202400708

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication